当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3224961
自主品牌
已选条件
-
T12706Reslizumab；化合物 T12706Sch 55700；Sch 55700
Reslizumab is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma.
价 格：￥电议型 号：T12706产 地：中国大陆
-
T1230Pamabrom巴马溴巴马溴|||帕马溴
Pamabrom is a diuretic, used for the relief of temporary water weight gain, bloating, swelling and full feeling associated with the premenstrual and menstrual periods.
价 格：￥电议型 号：T1230产 地：中国大陆
-
T12177Natalizumab；那他珠单抗Natalizumab
Natalizumab used for the treatment of relapsing remitting multiple sclerosis and Crohn´s disease.
价 格：￥电议型 号：T12177产 地：中国大陆
-
T11126Durvalumab；度伐利尤单抗MEDI 4736；MEDI 4736
Durvalumab (MEDI 4736) is a humanized monoclonal antibody targeting PD-L1. It can block the interaction of PD-L1 with PD-1 and CD80, with IC50 values of 0.1 and 0.04 nM, respectively. Durvalumab is often used in combination with platinum-based compounds for the treatment of non-small cell lung cancer and advanced hepatocellular carcinoma cells.
价 格：￥电议型 号：T11126产 地：中国大陆
-
T10497Benralizumab贝那利珠单抗BIW-8405|||MEDI-563
Benralizumab (MEDI-563) is a monoclonal antibody targeting the interleukin-5 receptor alpha (IL-5Rα). It enhances antibody-dependent cell-mediated cytotoxicity, leading to a rapid depletion of eosinophils. Benralizumab is used for severe eosinophilic asthma and can be employed to prevent exacerbations of chronic obstructive pulmonary disease.
价 格：￥电议型 号：T10497产 地：中国大陆
